Replying to @arvindcanchi
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
GBA+BWSSB+Bescom officials work together to get construction completed. Temporary utility services like water/sanitary & electricity is continued even after construction completed. Without OC/CC both illegal high-rise buildings are operating as PG/Colive.
@krishnabgowda
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
Newly released 🔥🔥
Updated NICE Guidelines: Initial Pharmacologic Management of Type 2 Diabetes:
🔵 Chronic kidney disease:
🔵 eGFR >30: Metformin MR + SGLT-2 inhibitor; if metformin not tolerated → SGLT-2 inhibitor alone.
🔵 eGFR 20–30: Dapagliflozin or empagliflozin + DPP-4 inhibitor.
🔵 eGFR <20: Consider DPP-4 inhibitor; if unsuitable → consider pioglitazone or insulin.
#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare
@mvaduganathan @hvanspall @ShelleyZieroth @DrMarthaGulati @goKDIGO @ASNKidney @biljana_parapid @Hragy
nice.org.uk/guidance/ng28/ch…
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
🫘💯Easy guide to AKI
From @Neph_SIM
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
👍New Lupus Nephritis guidelines
#ACR2024
🤘Major change-Triple therapy for induction ✅
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
Kidney transplant recipients receiving GLP-1 RA had a 49% lower incidence of death-censored graft loss and 31% lower mortality than those not receiving GLP-1 RA 🤯
Proud to be a co-author on this real-world retrospective cohort study of 18,106 kidney transplant recipients with diabetes published today in Lancet Diabetes and Endocrinology🙂
Article: sciencedirect.com/science/ar…
Accompanying commentary: thelancet.com/journals/landi…
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
Type of probe
#ultrasound
#sonologist
Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin retweeted
🦠Hepatitis B serology
By @PathwayMedical































